NO961808L - Konstruksjon og produksjon av vaksine - Google Patents

Konstruksjon og produksjon av vaksine

Info

Publication number
NO961808L
NO961808L NO961808A NO961808A NO961808L NO 961808 L NO961808 L NO 961808L NO 961808 A NO961808 A NO 961808A NO 961808 A NO961808 A NO 961808A NO 961808 L NO961808 L NO 961808L
Authority
NO
Norway
Prior art keywords
val
ile
leu
gly
ala
Prior art date
Application number
NO961808A
Other languages
English (en)
Other versions
NO961808D0 (no
Inventor
Curtis Coats Scheifinger
David Lee Smiley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO961808D0 publication Critical patent/NO961808D0/no
Publication of NO961808L publication Critical patent/NO961808L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/085Staphylococcus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00Drug, bio-affecting and body treating compositions
    • Y10S424/823Bacterial vaccine for bovine species, e.g. cattle

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Peptider avledet fra proteiner assosiert med bakteriell adherering til bryst duktilt epitelium er nyttige for fremstilling av vaksiner for å forhindre brystbetennelse. Fremgangsmåter for å bestemme mikrobiell adherens tilveiebringer rasjonell vaksinekonstruksjon. Peptidene har den generelle formelen: Rl-R2.R3-R4.R5.R6.R7.R8.Gly-RlO.Gly-Rl2.Rl3.Rl5.Rl6.Aia.Rl8.Arg.Aia.R21. Gln-Gly-R24 hvor R! er hydrogen eller Cj-Cig karboksylsyre; R2 er Ala, Gly, Ser eller propionsyre; R3 er Val, Ile, Leu eller D-Val; R4 er Lys eller Arg; R5 er Val, Ile eller Leu; R6 er Ala, Gly eller Ser; R? er Ile, Leu eller Val; R8 er Asp, Asn eller Glu; RlOerPhe,TyrellerTrp; R! 2 er Arg, Asn, Lys eller His; Ri3 er Ile, Leu eller Val; Ri 5 er Arg, Asn, Lys eller His; Ri 6 er Leu, Ala, Ile eller Val; R18 er Phe, Asn, Lys eller His; R21 er Ile, Ala, Val eller Leu; R24 er OH, Ala eller Ser.
NO961808A 1993-11-05 1996-05-03 Konstruksjon og produksjon av vaksine NO961808L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14776593A 1993-11-05 1993-11-05
PCT/US1994/012752 WO1995012410A1 (en) 1993-11-05 1994-11-04 Vaccine design and production

Publications (2)

Publication Number Publication Date
NO961808D0 NO961808D0 (no) 1996-05-03
NO961808L true NO961808L (no) 1996-06-27

Family

ID=22522813

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961808A NO961808L (no) 1993-11-05 1996-05-03 Konstruksjon og produksjon av vaksine

Country Status (21)

Country Link
US (1) US5679349A (no)
EP (1) EP0726774A4 (no)
JP (1) JPH09505039A (no)
KR (1) KR960705582A (no)
CN (2) CN1087953C (no)
AU (1) AU1050595A (no)
BR (1) BR9407988A (no)
CA (1) CA2175708A1 (no)
CZ (1) CZ128896A3 (no)
FI (1) FI961869A (no)
HU (1) HUT75556A (no)
NO (1) NO961808L (no)
NZ (1) NZ276290A (no)
PL (1) PL314303A1 (no)
RO (1) RO116045B1 (no)
RU (1) RU2143920C1 (no)
SG (1) SG49830A1 (no)
TW (1) TW448185B (no)
UA (1) UA42741C2 (no)
WO (1) WO1995012410A1 (no)
ZA (1) ZA948590B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1089751A4 (en) * 1998-06-23 2001-07-25 Univ Leland Stanford Junior ADJUVANTE THERAPY
JP2003171291A (ja) * 1999-10-29 2003-06-17 Takeda Schering-Plough Animal Health Kk 乳房炎用粘膜予防剤
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
GB0219524D0 (en) 2002-08-21 2002-10-02 Queen Mary & Westfield College Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
GB0802931D0 (en) 2008-02-18 2008-03-26 Queen Mary & Westfield College Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions
CN102716475A (zh) * 2012-06-29 2012-10-10 黑龙江省科学院微生物研究所 一种奶牛乳房炎疫苗的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0672123A1 (en) * 1992-01-08 1995-09-20 The Rockefeller University Multifunctional surface protein of streptococci

Also Published As

Publication number Publication date
EP0726774A1 (en) 1996-08-21
SG49830A1 (en) 1998-06-15
RU2143920C1 (ru) 2000-01-10
HUT75556A (en) 1997-05-28
KR960705582A (ko) 1996-11-08
PL314303A1 (en) 1996-09-02
WO1995012410A1 (en) 1995-05-11
CN1141000A (zh) 1997-01-22
CZ128896A3 (en) 1996-10-16
FI961869A0 (fi) 1996-05-02
UA42741C2 (uk) 2001-11-15
EP0726774A4 (en) 2001-06-27
CN1087953C (zh) 2002-07-24
BR9407988A (pt) 1996-12-03
CA2175708A1 (en) 1995-05-11
HU9601191D0 (en) 1996-06-28
JPH09505039A (ja) 1997-05-20
US5679349A (en) 1997-10-21
AU1050595A (en) 1995-05-23
RO116045B1 (ro) 2000-10-30
FI961869A (fi) 1996-05-02
TW448185B (en) 2001-08-01
CN1380422A (zh) 2002-11-20
NO961808D0 (no) 1996-05-03
NZ276290A (en) 1997-11-24
ZA948590B (en) 1996-05-02

Similar Documents

Publication Publication Date Title
CA2052375C (en) Parathyroid hormone derivatives
DE59007517D1 (de) Neue proteine mit tnf-hemmender wirkung und ihre herstellung.
CA1267997A (en) Polypeptides and process for the production thereof
AU2003210722B9 (en) Bioactive keratin peptides
Kobayashi et al. Hymenamides A and B, new proline-rich cyclic heptapeptides from the Okinawan marine sponge Hymeniacidon sp.
US6399053B1 (en) Methods of enhancing bioactivity of chemokines
MX9604100A (es) Compuestos ciclicos, inhibidores de la adhesion.
CA1247605A (en) Crf analogs
KR940703854A (ko) 사람 쿠니즈형 프로테아제 저해제 변이체(a human kunitz-type protease inhibitor variant)
DE69002448T2 (de) Zyklische Pentapeptide als Endothelin-Antagonisten.
KR850008681A (ko) 합성펩티드의 제조방법
MXPA03001721A (es) Peptidos ciclicos selectivos.
AR006517A1 (es) Polipeptido que alcanza un total de alrededor de 30 aminoacidos; sustancia, peptidomimetico y composicion farmaceutica resultantes; usos del polipeptidoy proceso para la sintesis del polipeptido.
US6211151B1 (en) Peptides with organo-protective activity, a process for preparation thereof and their use in therapy
DK1000149T3 (da) 5'-EST'ere til udskilte proteiner identificeret fra hjernevæv
NO961808L (no) Konstruksjon og produksjon av vaksine
HUP0000320A2 (hu) Biológiailag aktív peptidek,és eljárás előállításukra
DE3880481D1 (de) Polypeptid und verfahren zu seiner herstellung.
US5633345A (en) Cyclic peptides
EP0621285A4 (en) NEW MEGAKARYOCYTE AMPLIFIER.
NO975565L (no) Benstimulerende faktor
HUP0003357A2 (hu) Angiogén hatású ciklusos azapeptidek, ezeket hatóanyagként tartalmazó gyógyászati készítmények, eljárás ezek előállítására és alkalmazásuk
TW200517123A (en) Nogo-A binding molecules and pharmaceutical use thereof
JP2003510257A5 (no)
BR9608482A (pt) Genes receptores de transferrina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application